THE REAL SUCCESS OF BIOTECHNOLOGY WILL NOT BE MEASURED BY HOW ADVANCED OUR LABORATORIES BECOME, BUT BY HOW EFFECTIVELY THEIR DISCOVERIES REACH ORDINARY PEOPLE.
By Dr. Anu Kumar
Healthcare is entering a remarkable technological era. Scientists can now read genomes, develop advanced vaccines, engineer microorganisms, create rapid diagnostic tests and use artificial intelligence to analyze complex biological information. Yet for millions of people, particularly in rural and underserved areas, the most important question remains simple: can these scientific advances make healthcare more accessible and affordable?
A discovery has limited social value if it remains confined to a sophisticated laboratory. The real achievement begins when that discovery reaches a patient. Biotechnology has enormous potential to bridge this gap, particularly through affordable diagnostics, vaccines, biological medicines and preventive healthcare.Diagnostics are perhaps one of the most promising areas. Many diseases become difficult and expensive to treat because they are detected late.
People living in villages may have to travel considerable distances to access specialized laboratories, increasing both the financial and emotional burden on families. Biotechnology can change this situation through portable diagnostic devices, biosensors and rapid molecular tests that bring sophisticated testing closer to the patient.
Imagine a healthcare worker in a village being able to identify an infectious disease within minutes rather than sending a sample to a distant laboratory.Such technologies could enable earlier treatment, reduce unnecessary antibiotic use and prevent complications. Artificial intelligence can further support this transformation by helping healthcare professionals analyze medical images, laboratory results and biological data, particularly where specialist expertise is limited. AI should not replace doctors; rather, it should help extend their reach.Vaccines and biological medicines represent another major opportunity.
Advances in biotechnology have demonstrated how modern scientific platforms can rapidly respond to infectious diseases. Strengthening India’s capacity to develop and manufacture vaccines, diagnostic reagents and biological medicines domestically can improve healthcare security and potentially reduce costs.
However, affordability is not simply a matter of producing a cheaper technology. A low-cost diagnostic device will have little impact if a village health center lacks electricity, trained personnel, connectivity or a system for follow-up treatment.Biotechnology must therefore be accompanied by investment in healthcare infrastructure, training and public-health systems.India should also encourage stronger collaboration between universities, biotechnology companies, hospitals and government agencies. Researchers need support not only to publish scientific discoveries but also to translate them into practical technologies that address real societal problems. Local communities should be viewed not merely as consumers of biotechnology but as partners in identifying the challenges that innovation should solve.
The future of biotechnology should not be restricted to metropolitan hospitals and high-end laboratories. It should reach district hospitals, primary health centers and village clinics. It should help detect diseases earlier, prevent infections, reduce unnecessary medical expenses and improve the quality of life of ordinary families.India possesses scientific talent, pharmaceutical expertise and a growing biotechnology ecosystem. The next challenge is to ensure that this strength produces benefits that are widely shared.
The greatest biotechnology breakthrough may not be the one that attracts the most attention in a scientific journal. It may be a simple, affordable technology that reaches a remote village, detects a disease early and saves a family’s money—and perhaps a patient’s life.
The laboratory is where innovation begins. But its true success will be measured by how far that innovation travels.(Writer is an Associate Professor Biotechnology Department Chandigarh University, Mohali, Punjab)
